Optical Isomerism & Chirality in Medicines
In 1957, Grünenthal GmbH marketed thalidomide as a sedative for morning sickness. By 1961, it was withdrawn after 10,000 children were born with severe limb malformations across 46 countries. The R-enantiomer was the therapeutic sedative; the S-enantiomer was teratogenic. Both were present in the racemic mixture sold as Contergan.
Practise this lesson
Four printable worksheets that build from the foundations up to exam-style questions — start at whatever level suits you.
A student says, "If two drug molecules have the same molecular formula and the same functional groups, they must have the same biological effect."
- What is chemically wrong with that statement?
- Why might a biological receptor distinguish between mirror-image molecules?
Know
- The definition of a chiral centre and an enantiomer
- The meaning of a racemic mixture
- The role of polarimetry in detecting optical activity
Understand
- How enantiomers differ from structural and geometric isomers
- Why enantiomers can have different biological activity despite similar physical properties
- Why modern drug development prefers enantiopure products when possible
Can Do
- Identify chiral centres in common drug structures
- Explain the thalidomide case clearly and accurately
- Classify molecules as chiral, achiral, racemic or optically active
Core Content
A stereogenic centre creates non-superimposable mirror images
A molecule is chiral if it cannot be superimposed on its mirror image. In this course, the key structural clue is a chiral centre, usually a carbon bonded to four different groups.
When a carbon has four different substituents, two different three-dimensional arrangements become possible. These are mirror images of each other, but they are not identical. That gives a pair of enantiomers.
A chiral centre is a carbon atom bonded to four different groups (a stereocentre). Two different three-dimensional arrangements are possible, producing non-superimposable mirror images called enantiomers.
Pause — copy the highlighted definition into your book.
Same formula, different kind of difference
We just saw that a chiral centre creates two non-superimposable mirror images. That raises a question: how are enantiomers different from the other isomers we know? This card answers it → the source of the difference is not connectivity or restricted rotation, but three-dimensional mirror-image arrangement.
It is important not to mix up enantiomers with other types of isomers, because the source of the difference is not the same.
Enantiomers usually have the same molecular formula, the same connectivity, and many of the same physical properties. Their difference lies in the way they occupy three-dimensional space.
Structural isomers differ in connectivity; geometric isomers differ in arrangement around a restricted bond; enantiomers have the same connectivity and differ only in their non-superimposable mirror-image 3D arrangement.
Pause — copy the highlighted comparison into your book.
Biological systems are chiral too
We just saw that enantiomers share connectivity and many physical properties. That raises a question: if they are so similar, why would they behave differently as medicines? This card answers it → biological binding sites are themselves chiral, so they can distinguish mirror-image molecules.
Enantiomers often have very similar physical properties in non-chiral environments, but biological environments are not non-chiral. Enzymes, receptors and many biomolecules can distinguish between left- and right-handed molecular arrangements.
That means one enantiomer may bind well to a target and produce a therapeutic effect, while the other may bind weakly, be inactive, or even produce harmful effects. This is why chirality matters so much in medicines.
Biological receptors and enzymes are chiral structures. They can distinguish between two mirror-image molecular arrangements, so one enantiomer may be therapeutic while the other is inactive or harmful.
Pause — copy the highlighted explanation into your book.
Biological receptors are chiral environments. Two enantiomers can therefore interact differently with the same target, even when they have the same atoms and connectivity.
A major lesson in medicinal stereochemistry
We just saw that chiral receptors can distinguish enantiomers. That raises a question: what happens when a drug is administered as a 50:50 mixture of both? This card answers it → the thalidomide tragedy shows exactly how dangerous that assumption can be.
Thalidomide is studied because it shows how a failure to appreciate stereochemistry can have devastating consequences.
In the syllabus framing, the R-enantiomer of thalidomide is associated with sedative effects, while the S-enantiomer is associated with teratogenic effects. A racemic mixture is a 50:50 mixture of enantiomers. When thalidomide was used as a racemic mixture, birth defects resulted.
This history is one reason modern drug development strongly prefers enantiopure drugs where possible, rather than assuming both enantiomers are equally safe or useful.
A racemic mixture is a 50:50 mixture of two enantiomers and is optically inactive. Thalidomide: R-enantiomer (sedative), S-enantiomer (teratogenic). Modern drug development prefers enantiopure drugs for better control over biological action.
Pause — copy the highlighted thalidomide summary into your book.
From structure recognition to polarimetry
We just saw that enantiopure drugs are preferred over racemic mixtures. That raises a question: how do chemists detect whether a sample is optically active or a racemic mixture? This card answers it → polarimetry measures the rotation of plane-polarised light to provide that experimental evidence.
A chemist suspects a new drug batch may have racemised during synthesis. She places the sample in a polarimeter — plane-polarised light enters, and the analyser shows zero net rotation. That zero rotation does not mean the drug is chemically pure: it means the two enantiomers are present in equal amounts, cancelling each other's rotation. A racemic mixture passes a polarimetry test with the same result as an optically inactive achiral compound. This is why chirality must first be recognised structurally (by identifying chiral centres), then measured experimentally (by polarimetry), and then verified by chiral HPLC if safety requires enantiopure product.
You should be able to identify possible chiral centres in molecules such as ibuprofen, thalidomide and many amino acids. By contrast, aspirin does not contain a chiral centre in the usual HSC representation, so it is a useful comparison molecule.
Polarimetry is used to detect optical activity by measuring the rotation of plane-polarised light as it passes through a sample. A pure enantiomer can rotate plane-polarised light, while a racemic mixture shows no net rotation because the rotations cancel.
Polarimetry measures the rotation of plane-polarised light. A pure enantiomer rotates it; a racemic mixture shows zero net rotation because the effects of both enantiomers cancel. Polarimetry is experimental evidence of optical activity, not structural identification.
Pause — copy the highlighted polarimetry point into your book.
Polarimetry does not identify the whole structure. It measures how much plane-polarised light is rotated by the sample, providing evidence that a sample is optically active.
No - it would likely still have been harmful. In vivo, the body can interconvert the two enantiomers via racemisation (chiral inversion). Even a pure R-enantiomer dose would partially convert to the teratogenic S-enantiomer. This illustrates why each enantiomer must be independently assessed in drug development.
Complete the Learn phase to unlock Practice.
Activities
Decide whether each case is best described as structural, geometric, enantiomeric or not an isomer pair at all.
1. Two molecules have the same molecular formula but differ in which atoms are connected.
2. Two molecules are mirror images and cannot be superimposed.
3. Two molecules differ because a double bond prevents free rotation and the groups are arranged differently in space.
Use the structure or sample description to decide what kind of chirality behaviour is present.
1. A molecule contains a carbon bonded to four different groups.
2. A pharmaceutical sample contains equal amounts of two enantiomers.
3. A pure drug sample rotates plane-polarised light.
Check Your Understanding
1. What is a chiral centre in the context of this course?
2. Which statement best distinguishes enantiomers from structural isomers?
3. Why can two enantiomers have different biological activity even though many physical properties are similar?
4. What is a racemic mixture?
5. Which statement about polarimetry is correct?
1. Define a chiral centre and explain how it can give rise to a pair of enantiomers. (4 marks)
2. Explain why enantiomers can have different biological activity even though they have similar physical properties in many non-biological settings. (5 marks)
3. Evaluate why modern drug development prefers enantiopure drugs rather than racemic mixtures, with reference to the thalidomide case. (5 marks)
Show All Answers
Activity 1
1. This is structural isomerism because the connectivity of atoms differs.
2. This is a pair of enantiomers because the molecules are non-superimposable mirror images.
3. This is geometric isomerism because restricted rotation around a double bond gives different spatial arrangements.
Activity 2
1. This suggests the molecule may be chiral because the carbon is bonded to four different groups, creating a stereogenic centre.
2. This sample is racemic. Its polarimetry result would show no net rotation because the effects of the two enantiomers cancel.
3. This indicates the sample is optically active and is not a simple 50:50 racemic mixture.
Multiple Choice
1. C — a chiral centre is a carbon bonded to four different groups.
2. B — enantiomers keep the same connectivity but differ in mirror-image 3D arrangement.
3. D — chiral receptors can distinguish enantiomers.
4. A — a racemic mixture is a 50:50 mixture of enantiomers.
5. C — polarimetry measures rotation of plane-polarised light to detect optical activity.
Short Answer Model Answers
Q1 (4 marks): A chiral centre is usually a carbon atom bonded to four different groups. Because those four groups can be arranged in two different three-dimensional mirror-image ways, a pair of non-superimposable mirror images can result. These are called enantiomers.
Q2 (5 marks): Enantiomers have the same molecular formula and the same connectivity, so in many non-chiral settings they have similar physical properties. However, biological systems such as enzymes and receptors are themselves chiral. This means they can distinguish between two mirror-image molecular arrangements. As a result, one enantiomer may bind effectively and produce a therapeutic response, while the other may bind differently, be inactive or even be harmful.
Q3 (5 marks): Modern drug development prefers enantiopure drugs because different enantiomers can have very different biological effects even though they look very similar on paper. The thalidomide case shows why this matters: in the syllabus framing, the R-enantiomer had sedative effects while the S-enantiomer was teratogenic, and the racemic mixture caused birth defects. Using enantiopure drugs helps chemists and pharmacologists control the biological action more precisely and reduce the risk of unwanted effects from the other enantiomer. Overall, chirality is a major safety and efficacy issue, not just a naming detail.
Return to the 1957 thalidomide disaster. Now that you understand chirality, enantiomers, and polarimetry, explain why the tragedy occurred and how modern drug development would prevent it.
- Explain specifically why Grünenthal's racemic thalidomide mixture caused birth defects in 10,000 children — using the terms R-enantiomer, S-enantiomer, chiral centre, and biological receptor specificity.
- If a pharmacologist in 1957 had run polarimetry on pure R-thalidomide, pure S-thalidomide, and the racemic Contergan mixture, what rotation result would each have produced — and why would that still not have identified which enantiomer was dangerous?
- Write one sentence explaining what additional test beyond polarimetry would be needed to separate and verify the safety of each thalidomide enantiomer.
Review
What is a chiral centre?
What is a racemic mixture and what does polarimetry show for one?
Why did thalidomide cause harm when given as a racemic mixture?
How do enantiomers differ from structural isomers?
Why can biological receptors distinguish between enantiomers?